New Year, New Contagion®: Section Editor Lineup Brings Expertise, Insight for 2019
Jason Gallagher, PharmD, FCCP, FIDP, FIDSA, BCPS, kicks off his second year as editor-in-chief by welcoming 6 industry experts on as section editors.
Final Diagnosis: Disseminated Kaposi Sarcoma With Tonsillar and Pulmonary Involvement
A shocking find on a CT scan leads to an unexpected diagnosis.
Potential Two-Dose Dalbavancin Treatment for Osteomyelitis
Although dalbavancin is currently approved by the US Food and Drug Administration for the treatment of skin and soft tissue infections, its distinctive pharmacokinetic profile has piqued curiosity regarding its place in therapy for infections requiring long durations of antibiotics, such as osteomyelitis.
Duration of Antibiotic Therapy for Uncomplicated Gram-Negative Bacteremia: Seven Is the New Fourteen
The treatment duration for uncomplicated gram-negative bloodstream infections (BSIs) has traditionally ranged from 7 to 14 days. However, recent retrospective studies and meta-analyses have observed no differences in clinical outcomes in patients treated with shorter courses compared with prolonged courses, especially with urinary sources of infection.
2 Clarke Drive Cranbury, NJ 08512